Duration and timing of bisphosphonate treatment as factors determining osteoblast mineralization
Background: Alendronate is a drug for the treatment of excessive bone resorption. Alendronate reduces osteoblast viability and mineralization in a dose-dependent manner. Other views of alendronate could affect mineralization. Therefore, the effects of timing and duration of alendronate treatment on...
Saved in:
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Journal of Oral Biology and Craniofacial Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212426822000884 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|